genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Novo Nordisk
Industry News
Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Drug Discovery
StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Drug Discovery
Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline
Bioprocessing
Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Artificial Intelligence
GTC 2024: Nvidia’s Quantum Expansion Runs through the Cloud
Drug Discovery
89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field
Cancer
StockWatch: Madrigal Shares Soar as FDA Nears Historic MASH Decision
Drug Discovery
International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions
Drug Discovery
StockWatch: Challengers Take Aim at Lilly, Novo Nordisk
Drug Discovery
Novo Nordisk Expands Boston Area Research and Early Development
1
2
Page 1 of 2
Scroll Up